Evidence map›Paper›PMID 41080420›Full record

ArticleExploratory research in clinical and social pharmacy2025

Increasing access: Making naloxone available at highway rest areas.

Tim Ingram, Sofia Rubi, Jennifer L Brown, Joel Sprunger, Aimee Shadwick, Clark Crago, Michael S Lyons, T John Winhusen

Abstract read
In one paragraph

Article in Exploratory research in clinical and social pharmacy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tim IngramUniversity of Cincinnati College of Medicine, Department of Psychiatry & Behavioral Neuroscience, Cincinnati, Ohio, USA.
Sofia RubiPurdue university, Department of Psychological Sciences, West Lafayette, Indiana, USA.
Jennifer L BrownPurdue university, Department of Psychological Sciences, West Lafayette, Indiana, USA.
Joel SprungerUniversity of Cincinnati College of Medicine, Department of Psychiatry & Behavioral Neuroscience, Cincinnati, Ohio, USA.
Aimee ShadwickRecoveryOhio, Columbus, Ohio, USA.
Clark CragoToronto Emergency Medical Services, Toronto, OH, USA.
Michael S LyonsThe Ohio State University, Department of Emergency Medicine, Columbus, Ohio, USA.
T John WinhusenUniversity of Cincinnati College of Medicine, Department of Psychiatry & Behavioral Neuroscience, Cincinnati, Ohio, USA.

Funding

Optimizing HEALing in Ohio Communities (OHiO)-Health Equity SupplementUM1DA049417 · NIDA · OHIO STATE UNIVERSITY · PI FREISTHLER, BRIDGET J, WINHUSEN, T JOHN · 2019 to 2023
$66.3M
NIDA NIH HHS UM1 DA049417
6 · The paper itself

Abstract

Background: Naloxone is one of the most successful drugs in reversing the pharmacological effects of opioids and, in turn, preventing overdose. Increasing naloxone availability is an effective way to combat opioid-related overdose deaths. Recent changes in legislation across the United States have provided the jurisdiction to make naloxone more readily available. Naloxboxes are transparent, unsecured containers stocked with naloxone that are strategically placed in semi-private public spaces, such as restrooms. Objective: To assess the effectiveness of installing naloxboxes at highway rest areas in Ohio as a strategy to increase public access to naloxone. This assessment draws on the pilot partnerships with the Ohio Department of Transportation, emergency medical services, and public health agencies, and explores implications for broader community implementation. Methods: In collaboration with existing Ohio organizations, the HEALing Communities Study leveraged local and national funding to facilitate the expansion of naloxone use through the deployment of naloxone boxes at Ohio highway rest areas. Results: Naloxboxes were found to be well accepted by the public and sustainable in highway rest areas. Their successful implementation and ongoing maintenance relied on multisectoral support, requiring collaboration across community organizations, public health agencies, and other stakeholders. Conclusion: This innovative approach promoted the widespread distribution of naloxone while still preserving anonymity.

Indexed as

AddictionNaloxoneOpioid overdose prevention

Identifiers

PMID41080420
PMCPMC12513219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.